360
Participants
Start Date
September 1, 2025
Primary Completion Date
September 1, 2027
Study Completion Date
September 1, 2028
Ketorolac
patients in the experimental group will receive ketorolac treatment for Stanford Type A aortic dissection, consisting of a 60mg intramuscular injection preoperatively followed by 30mg twice daily for two days postoperatively, while maintaining standard baseline therapies including analgesia, blood pressure control, and subsequent cardiovascular surgical management.
0.9 % saline
0.9% saline
Nanjing Drum Tower Hospital, Nanjing
Guangdong Provincial People's Hospital
OTHER
Huai'an First People's Hospital
OTHER
Shandong Provincial Hospital
OTHER_GOV
First Affiliated Hospital of Harbin Medical University
OTHER
The Second Affiliated Hospital of Harbin Medical University
OTHER
THE FIRST AFFILIATED HOSPITAL OF SHIHEZI UNIVERSITY
UNKNOWN
Xinhua Hospital of Ili Kazak Autonomous Prefecture
UNKNOWN
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
OTHER